FDA inspection
Nesher Pharmaceuticals (USA) LLC: FDA inspection ending Aug 12, 2021
FDA inspection 1151305 · Voluntary Action Indicated (VAI) · Saint Louis, MO
Key facts
| Inspection ID | 1151305 |
|---|---|
| Firm | Nesher Pharmaceuticals (USA) LLC |
| FEI number | 1937079 |
| Address | 2303 Schuetz Rd |
| City | Saint Louis |
| State | MO |
| ZIP | 63146 |
| Country | United States |
| Fiscal year | 2021 |
| Inspection end date | Aug 12, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data